Editorial Team

Editor-in-Chief

  1. Mondher Toumi, MD, MSc, PhD, Professor & Chair of Public Health. & Market Access, and Professor, UFR d'Odontologie, University. Claude Bernard Lyon 1, France

Editorial Manager

  1. Emna El Hammi, Editorial Manager Journal of Market Access and Health Policy www.jmahp.net European Market Access University Diploma University Claude Bernard Lyon 1 www.emaud.org, France

Editorial Board

  1. Lieven Annemans, Department of Public Health, Ghent University, and Vrije Universiteit Brussel, Belgium
  2. Alexander Bakhutashvili, Valexpharm, Russian Federation
  3. Jaime Espin, Professor Andalusian School of Public Health, Spain
  4. Joshua Cohen, Tufts Center for the Study of Drug Development, Boston, MA, United States
  5. Dávid Dankó, Institute of Management of Corvinus University, Hungary, University of Claude Bernard Lyon I, Hungary
  6. Julie M. Donohue, Department of Health Policy and Management, University of Pittsburg, United States
  7. Gérard Duru, University of Lyon I, France
  8. Clément François, Lundbeck LLC, France
  9. Amiram Gafni, Department of Clinical Epidemiology & Biostatistics, McMaster University, Canada
  10. Chantal Guilhaume, Sanofi, France
  11. Maarten J. Ijzerman, School for Management & Governance, Dept. Health Technology & Services Research, University of Twente, Netherlands, and Case Western Reserve University, Cleveland, OH, United States
  12. Claudio Jommi, Phamraceuticals Observatory, CERGAS Bocconi University, Italy
  13. Oleg Karpov, Sanofi Aventis, Russian Federation
  14. Eui-Kyung Lee, School of Pharmacy, Sungkyunkwan University, Seoul, Korea, Democratic People's Republic of
  15. Gilberto de Lima Lopes, Jr, The Johns Hopkins Singapore International Medical Centre, and The Johns Hopkins University School of Medicine, Singapore
  16. Márcio Machado, GlaxoSmithKline, Brazil
  17. Dr. Josephine A. Mauskopf, RTI Health Solutions, United States
  18. Guillermo Melendez, Mexican Health Foundation, Mexico
  19. Nicholas Moore, Pharmacology Department, University of Bordeaux 2, France
  20. Thomas Müller, G-BA, Germany
  21. Isaac A. O. Odeyemi, Astellas, United Kingdom
  22. Chris L. Pashos, United Biosource Corporation, United States
  23. Ulf Persson, Health Economics at the Institute of Economic Research, School of Economics and Management, Lund University, and Swedish Institute for Health Economics, Sweden
  24. Christelle Saint Sardos, Sanofi Pasteur, France
  25. Prof. Dr. Michael Schlander, University of Heidelberg and Institute for Innovation & Valuation in Health Care, Germany
  26. Floortje van Nooten, Astellas Pharma BV
  27. John Yfantopoulos, University of Athens, Greece
  28. Vladimir Zah, ZRx Outcomes Research Inc., Canada